Cargando…

CAR-T Cell Therapy in Diffuse Large B Cell Lymphoma: Hype and Hope

Patients with non-Hodgkin lymphomas (NHLs) resistant to standard therapies have a dismal prognosis. The outcome is even poorer in patients relapsing after autologous stem cell transplantation. Most of these patients do not qualify for an allogeneic hematopoietic cell transplantation (HCT) due to ref...

Descripción completa

Detalles Bibliográficos
Autores principales: Hopfinger, Georg, Jäger, Ulrich, Worel, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746029/
https://www.ncbi.nlm.nih.gov/pubmed/31723824
http://dx.doi.org/10.1097/HS9.0000000000000185